{"id":2739,"date":"2026-03-24T19:54:17","date_gmt":"2026-03-24T16:54:17","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=2739"},"modified":"2026-03-24T21:23:21","modified_gmt":"2026-03-24T18:23:21","slug":"dmd-associations-failure-treatment-access","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/tr\/dmd-associations-failure-treatment-access\/","title":{"rendered":"DMD Derneklerinin Sistematik Ba\u015far\u0131s\u0131zl\u0131\u011f\u0131: Duchenne Hastalar\u0131 Neden Hala Bekliyor?"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Duchenne kas distrofisi (DMD) yeni ke\u015ffedilmi\u015f bir hastal\u0131k de\u011fildir, \u00e7\u00f6z\u00fcms\u00fcz de de\u011fildir. Son yirmi y\u0131ldaki bilimsel ilerlemeler, ekzon atlama terapileri, kortikosteroid optimizasyon protokolleri ve en \u00f6nemlisi, b\u00fcy\u00fck d\u00fczenleyici kurumlar taraf\u0131ndan zaten onaylanm\u0131\u015f gen terapileri ortaya \u00e7\u0131karm\u0131\u015ft\u0131r. Bununla birlikte, d\u00fcnyan\u0131n b\u00fcy\u00fck bir b\u00f6l\u00fcm\u00fcnde, DMD'li \u00e7ocuklar tedavi edilmeden kalmaktad\u0131r; bunun nedeni tedavilerin mevcut olmamas\u0131 de\u011fil, tedavileri sunmak i\u00e7in tasarlanm\u0131\u015f sistemlerin ba\u015far\u0131s\u0131z olmas\u0131d\u0131r.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Bu ba\u015far\u0131s\u0131zl\u0131\u011f\u0131n merkezinde rahats\u0131z edici bir ger\u00e7ek yat\u0131yor: <strong>DMD ile ilgili bir\u00e7ok dernek ve vak\u0131f sadece beklentilerin alt\u0131nda performans g\u00f6stermekle kalmam\u0131\u015f, ayn\u0131 zamanda yap\u0131sal olarak da etkisiz hale gelmi\u015ftir.<\/strong>. Daha da k\u00f6t\u00fcs\u00fc, baz\u0131 durumlarda, savunuculuk yan\u0131lsamas\u0131n\u0131 yarat\u0131rken eylemsizli\u011fi normalle\u015ftirdiler.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Bu makale, s\u00f6z konusu ba\u015far\u0131s\u0131zl\u0131\u011f\u0131 sistematik, \u00e7ekinmeden ve kan\u0131ta dayal\u0131 bir ba\u011flamda ele\u015ftirel bir \u015fekilde inceliyor.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Daha fazla bilgi edin:<\/strong> <a href=\"https:\/\/dmdwarrior.com\/tr\/fda-approved-treatments-for-dmd\/\" target=\"_blank\" rel=\"noreferrer noopener\">FDA Onayl\u0131 DMD (Duchenne Musk\u00fcler Distrofi) Tedavileri<\/a><\/p>\n\n\n\n<div class=\"wp-block-rank-math-toc-block\" id=\"rank-math-toc\"><h2>\u0130\u00e7indekiler<\/h2><nav><ul><li><a href=\"#about-dmd\">Duchenne Kas Distrofisinde Savunuculuk Yan\u0131lsamas\u0131<\/a><\/li><li><a href=\"#the-global-inequality-in-dmd-treatment-access\">DMD Tedavisine Eri\u015fimde K\u00fcresel E\u015fitsizlik<\/a><\/li><li><a href=\"#bureaucracy-over-urgency-the-institutional-paralysis\">B\u00fcrokrasinin Aciliyetin \u00d6n\u00fcne Ge\u00e7mesi: Kurumsal Fel\u00e7<\/a><\/li><li><a href=\"#the-failure-to-apply-pressure\">Bask\u0131 Uygulamama Ba\u015far\u0131s\u0131zl\u0131\u011f\u0131<\/a><\/li><li><a href=\"#the-role-of-physicians-within-associations\">Hekimlerin Dernekler \u0130\u00e7indeki Rol\u00fc<\/a><\/li><li><a href=\"#pharmaceutical-companies-convenient-scapegoat-or-real-barrier\">\u0130la\u00e7 \u015eirketleri: Uygun Bir G\u00fcnah Ke\u00e7isi mi Yoksa Ger\u00e7ek Bir Engel mi?<\/a><\/li><li><a href=\"#political-failure-and-performative-support\">Siyasi Ba\u015far\u0131s\u0131zl\u0131k ve G\u00f6stermelik Destek<\/a><\/li><li><a href=\"#h-2-the-myth-of-nothing-can-be-done\">\u201cHi\u00e7bir \u015fey yap\u0131lamaz\u201d efsanesi<\/a><\/li><li><a href=\"#the-structural-weakness-of-dmd-associations\">DMD Derneklerinin Yap\u0131sal Zay\u0131fl\u0131\u011f\u0131<\/a><\/li><li><a href=\"#the-responsibility-to-deliver-not-just-represent\">Sadece temsil etmek de\u011fil, sonu\u00e7 elde etmek sorumlulu\u011fu<\/a><\/li><li><a href=\"#h-2-what-needs-to-change-immediately\">Hemen De\u011fi\u015ftirilmesi Gerekenler<\/a><\/li><li><a href=\"#dmd-associations-financial-transparency-and-accountability-issues\">DMD Derneklerinin Mali \u015eeffafl\u0131k ve Hesap Verebilirlik Sorunlar\u0131<\/a><\/li><li><a href=\"#misuse-of-funds-when-travel-takes-priority-over-patients\">Ba\u011f\u0131\u015flar\u0131n K\u00f6t\u00fcye Kullan\u0131m\u0131: Seyahat, Hastalar\u0131n \u00d6n\u00fcne Ge\u00e7ti\u011finde<\/a><\/li><li><a href=\"#faq\">S\u0131k\u00e7a Sorulan Sorular: \u00dclkenizdeki DMD Derneklerine Sorabilece\u011finiz Sorular!<\/a><\/li><li><a href=\"#h-2-conclusion\">Sonu\u00e7<\/a><\/li><\/ul><\/nav><\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"about-dmd\"><strong>Duchenne Kas Distrofisinde Savunuculuk Yan\u0131lsamas\u0131<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"awareness-without-outcomes\">Sonu\u00e7suz Fark\u0131ndal\u0131k<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">DMD dernekleri s\u0131kl\u0131kla kendilerini hasta savunucusu olarak konumland\u0131r\u0131rlar. Fark\u0131ndal\u0131k g\u00fcnleri d\u00fczenlerler, sosyal medyada i\u00e7erik yay\u0131nlarlar ve politika yap\u0131c\u0131larla toplant\u0131lar yaparlar. Ancak \u00f6l\u00e7\u00fclebilir sonu\u00e7lar olmadan fark\u0131ndal\u0131k yaratmak savunuculuk de\u011fil, sadece g\u00f6stermelik bir \u00e7abad\u0131r.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Temel soru \u015fu olmal\u0131d\u0131r:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Ka\u00e7 dernek, eylemlerinin do\u011frudan tedaviye eri\u015fim veya geri \u00f6deme ile sonu\u00e7land\u0131\u011f\u0131n\u0131 kan\u0131tlayabilir?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Bir\u00e7ok \u00fclkede bu sorunun cevab\u0131 ya belirsizdir ya da hi\u00e7 yoktur.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\">Ne s\u00f6z verdiniz, hedeflerinize ula\u015ft\u0131n\u0131z m\u0131 ve buna ra\u011fmen derne\u011finizin y\u00f6netimi neden hala ayn\u0131 ki\u015filerden olu\u015fuyor?<\/p>\n<\/blockquote>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"the-disparity-in-treatment-access\">\u00d6nemli Olan (Ama G\u00f6z Ard\u0131 Edilen) \u00d6l\u00e7\u00fctler<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Etkin savunuculuk \u015fu \u00f6l\u00e7\u00fctlerle de\u011ferlendirilmelidir:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>D\u00fczenleyici onaylar\u0131 al\u0131nd\u0131 m\u0131?<\/li>\n\n\n\n<li>Geri \u00f6deme g\u00fcvence alt\u0131na al\u0131nd\u0131 m\u0131?<\/li>\n\n\n\n<li>Tedavi edilen hasta say\u0131s\u0131 artt\u0131 m\u0131?<\/li>\n\n\n\n<li>Eri\u015fim s\u00fcresi azald\u0131 m\u0131?<\/li>\n\n\n\n<li>Klinik denemeye dahil edilme oranlar\u0131 artt\u0131 m\u0131?<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bunun yerine, dernekler genellikle \u015funlar\u0131 vurgular:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Toplant\u0131lar d\u00fczenlerler<\/li>\n\n\n\n<li>\u00c7ektikleri foto\u011fraflar\u0131 yay\u0131nlarlar<\/li>\n\n\n\n<li>Basit ve \u00f6nemli olmayan a\u00e7\u0131klamalar yay\u0131mlarlar<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"the-disparity-in-treatment-access\"><strong>Bu kopukluk, sonu\u00e7 odakl\u0131 hesap verebilirlikten performans odakl\u0131 kat\u0131l\u0131ma do\u011fru bir kaymay\u0131 yans\u0131t\u0131yor.<\/strong><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"the-global-inequality-in-dmd-treatment-access\"><strong>DMD Tedavisine Eri\u015fimde K\u00fcresel E\u015fitsizlik<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-3-a-two-tier-system-of-survival\">\u0130ki A\u015famal\u0131 Bir Hayatta Kalma Sistemi<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Amerika Birle\u015fik Devletleri veya Avrupa&#039;n\u0131n baz\u0131 b\u00f6lgeleri gibi \u00fclkelerdeki hastalar \u015fu gibi tedavilere eri\u015febiliyor:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Ekzon atlama terapileri<\/li>\n\n\n\n<li>Durmu\u015f kodon okuma tedavileri<\/li>\n\n\n\n<li>Yeni gen terapileri<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bu arada, bir\u00e7ok b\u00f6lgede:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Onaylanm\u0131\u015f herhangi bir tedavi y\u00f6ntemi mevcut de\u011fil.<\/li>\n\n\n\n<li>\u0130thalat k\u0131s\u0131tl\u0131d\u0131r.<\/li>\n\n\n\n<li>Geri \u00f6deme sistemleri ya yok ya da i\u015flevsiz.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Bu e\u015fitsizlik yaln\u0131zca ekonomik de\u011fil; zay\u0131f savunuculukla daha da k\u00f6t\u00fcle\u015fen \u00f6rg\u00fctsel ve siyasi bir ba\u015far\u0131s\u0131zl\u0131kt\u0131r.<\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"the-role-of-associations-in-this-inequality\">Bu E\u015fitsizlikte Derneklerin Rol\u00fc<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Derneklerin amac\u0131 bo\u015fluklar\u0131 kapatmakt\u0131r. Bunun yerine, bir\u00e7o\u011fu \u015funlar\u0131 yapm\u0131\u015ft\u0131r:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>D\u00fczenleyici kurumlarla etkili bir \u015fekilde ileti\u015fim kurmada ba\u015far\u0131s\u0131zl\u0131k<\/li>\n\n\n\n<li>Fiyatland\u0131rma yap\u0131lar\u0131yla \u00e7at\u0131\u015fmadan ka\u00e7\u0131nmak<\/li>\n\n\n\n<li>K\u00fcresel i\u015f birli\u011fini ihmal etmek<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bu bir paradoks yarat\u0131yor:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\"><strong>E\u015fitsizlikle m\u00fccadele etmek i\u00e7in kurulan \u00f6rg\u00fctler, eylemsizlikleriyle e\u015fitsizli\u011fi daha da peki\u015ftirdiler.<\/strong><\/p>\n<\/blockquote>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"bureaucracy-over-urgency-the-institutional-paralysis\"><strong>B\u00fcrokrasinin Aciliyetin \u00d6n\u00fcne Ge\u00e7mesi: Kurumsal Fel\u00e7<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-3-meetings-that-lead-nowhere\">Hi\u00e7bir Yere Varmayan Toplant\u0131lar<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Hastalar ve ailelerinden s\u0131kl\u0131kla gelen \u015fikayetlerden biri, a\u015fa\u011f\u0131dakilerle yap\u0131lan g\u00f6r\u00fc\u015fmelerden sonra \u015feffafl\u0131\u011f\u0131n ve takibin yetersiz olmas\u0131d\u0131r:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>H\u00fck\u00fcmet yetkilileri<\/li>\n\n\n\n<li>Sa\u011fl\u0131k bakanl\u0131klar\u0131<\/li>\n\n\n\n<li>\u0130la\u00e7 \u015firketleri<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bu toplant\u0131lar genellikle \u015fu sonu\u00e7larla sonu\u00e7lan\u0131r:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Herkese a\u00e7\u0131k bir yol haritas\u0131 sunulmaz<\/li>\n\n\n\n<li>Zaman \u00e7izelgesi payla\u015f\u0131lmaz<\/li>\n\n\n\n<li>Hesap verebilirlik mekanizmalar\u0131 bulunmaz<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bu durum kritik bir sorunu g\u00fcndeme getiriyor:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\"><strong>Bu giri\u015fimler stratejik \u00e7abalar m\u0131 yoksa sembolik jestler mi?<\/strong><\/p>\n<\/blockquote>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"the-culture-of-excuses\">Mazeret K\u00fclt\u00fcr\u00fc<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Yayg\u0131n anlat\u0131lar \u015funlard\u0131r:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\u201cBu s\u00fcre\u00e7 zaman al\u0131yor.\u201d<\/li>\n\n\n\n<li>\u201c\u0130la\u00e7lar \u00e7ok pahal\u0131.\u201d<\/li>\n\n\n\n<li>\u201cD\u00fczenleyici sistemler inan\u0131n \u00e7ok karma\u015f\u0131k.\u201d<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>K\u0131smen do\u011fru olsa da, bu a\u00e7\u0131klamalar eylemi motive etmek yerine eylemin yerini ald\u0131klar\u0131nda sorunlu hale gelirler.<\/strong><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"the-failure-to-apply-pressure\"><strong>Bask\u0131 Uygulamama Ba\u015far\u0131s\u0131zl\u0131\u011f\u0131<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-3-advocacy-without-confrontation-is-ineffective\">\u00c7at\u0131\u015fma olmadan yap\u0131lan savunma etkisizdir.<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Etkin hasta savunuculu\u011fu \u015funlar\u0131 gerektirir:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Politika bask\u0131s\u0131<\/li>\n\n\n\n<li>Medya etkile\u015fimi<\/li>\n\n\n\n<li>Hukuki zorluklar<\/li>\n\n\n\n<li>Uluslararas\u0131 ittifaklar<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Ancak bir\u00e7ok dernek \u00e7at\u0131\u015fmadan ka\u00e7\u0131narak bunun yerine \u015fu y\u00f6ntemleri tercih ediyor:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Diplomatik sessizlik<\/li>\n\n\n\n<li>Pasif m\u00fczakereler<\/li>\n\n\n\n<li>Ba\u011flay\u0131c\u0131 olmayan g\u00f6r\u00fc\u015fmeler<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bu isteksizlik onlar\u0131n temel misyonunu baltal\u0131yor.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"the-consequences-of-passive-advocacy\">Pasif Savunuculu\u011fun Sonu\u00e7lar\u0131<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Sonu\u00e7 tahmin edilebilir:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Geciken onaylar<\/li>\n\n\n\n<li>Tedavilerin geri \u00f6deme kapsam\u0131na al\u0131namamas\u0131<\/li>\n\n\n\n<li>Kaybedilen hasta zaman\u0131<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>DMD gibi ilerleyici bir hastal\u0131kta gecikme kabul edilebilir de\u011fildir; geri d\u00f6n\u00fc\u015f\u00fc olmayan bir zarard\u0131r.<\/strong><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"the-role-of-physicians-within-associations\"><strong>Hekimlerin Dernekler \u0130\u00e7indeki Rol\u00fc<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-3-the-expertise-paradox\">Uzmanl\u0131k Paradoksu<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Bir\u00e7ok dernekte \u00e7ocuk n\u00f6rologlar\u0131 ve genetik\u00e7iler liderlik pozisyonlar\u0131nda yer almaktad\u0131r. Bu bir avantaj olmal\u0131d\u0131r. Ancak bunun yerine, \u00e7o\u011fu zaman bir dezavantaja d\u00f6n\u00fc\u015fmektedir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Neden?<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u00c7\u00fcnk\u00fc:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Klinik uzmanl\u0131k, politika uzmanl\u0131\u011f\u0131 de\u011fildir.<\/li>\n\n\n\n<li>Bilimsel ihtiyat, stratejik fel\u00e7le kar\u0131\u015ft\u0131r\u0131l\u0131yor.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"criticism-without-contribution\">Katk\u0131da Bulunmadan Ele\u015ftiri<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Tekrarlayan bir \u00f6r\u00fcnt\u00fc ortaya \u00e7\u0131k\u0131yor:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Doktorlar mevcut tedavileri ele\u015ftiriyor.<\/li>\n\n\n\n<li>S\u0131n\u0131rlamalar\u0131 vurguluyor.<\/li>\n\n\n\n<li>Uzun vadeli etkinli\u011fi sorguluyor.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Ve sonucunda:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\u0130la\u00e7 geli\u015ftirme s\u00fcrecini ba\u015flatmazlar.<\/li>\n\n\n\n<li>Eri\u015fim programlar\u0131na \u00f6nc\u00fcl\u00fck etmezler.<\/li>\n\n\n\n<li>Sorumlulu\u011fu d\u0131\u015f akt\u00f6rlere devrederler.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bu durum, zarar verici bir dinamik yarat\u0131r:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\"><strong>Katk\u0131n\u0131n yerini ele\u015ftiri al\u0131yor.<\/strong><\/p>\n<\/blockquote>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"the-ethical-question\">Etik Soru<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">E\u011fer hekimler:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Mevcut tedaviler hakk\u0131nda ara\u015ft\u0131rma yapmazsa<\/li>\n\n\n\n<li>Tedavi g\u00f6ren hasta gruplar\u0131yla ileti\u015fime ge\u00e7mezse<\/li>\n\n\n\n<li>Eri\u015fim hakk\u0131n\u0131 sonuna kadar savunmazsa<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Bu durumda, derneklerdeki rolleri sorgulan\u0131r hale gelir.<\/strong><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"pharmaceutical-companies-convenient-scapegoat-or-real-barrier\"><strong>\u0130la\u00e7 \u015eirketleri: Uygun Bir G\u00fcnah Ke\u00e7isi mi Yoksa Ger\u00e7ek Bir Engel mi?<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-3-pricing-is-a-problem-but-not-the-only-one\">Fiyatland\u0131rma bir sorun, ancak tek sorun de\u011fil.<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">\u0130la\u00e7 \u015firketlerinin y\u00fcksek fiyatlar belirledi\u011fi yads\u0131namaz. Ancak:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Bir\u00e7ok \u00fclke lisans ba\u015fvurular\u0131n\u0131 hi\u00e7 alm\u0131yor<\/li>\n\n\n\n<li>Baz\u0131 d\u00fczenleyici kurumlar hi\u00e7bir zaman resmen devreye girmiyor<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bu \u015fu anlama geliyor:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\"><strong>Sorun sadece arz de\u011fil, ayn\u0131 zamanda talep bask\u0131s\u0131n\u0131n olmamas\u0131d\u0131r.<\/strong><\/p>\n<\/blockquote>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"the-silence-around-pricing\">Fiyatland\u0131rma Konusundaki Sessizlik<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Dernekler nerede bulunuyor:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Zorlu fiyatland\u0131rma modelleri mi?<\/li>\n\n\n\n<li>Kademeli fiyatland\u0131rmay\u0131 m\u0131 savunuyorsunuz?<\/li>\n\n\n\n<li>Eri\u015fim programlar\u0131 konusunda i\u015f birli\u011fi mi yap\u0131yorsunuz?<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>\u00c7o\u011fu durumda, bunlar ya mevcut de\u011fildir ya da etkisizdir.<\/strong><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"political-failure-and-performative-support\"><strong>Siyasi Ba\u015far\u0131s\u0131zl\u0131k ve G\u00f6stermelik Destek<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-3-symbolism-vs-policy\">Sembolizm ve Politika<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Politikac\u0131lar s\u0131kl\u0131kla:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Ailelerle g\u00f6r\u00fc\u015f\u00fcr<\/li>\n\n\n\n<li>Foto\u011fraflar\u0131 payla\u015f\u0131r<\/li>\n\n\n\n<li>Ba\u015fsa\u011fl\u0131\u011f\u0131 dileklerini iletir<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Ancak \u015fu konularda ba\u015far\u0131s\u0131z olurlar:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Fon (para) yaratmak<\/li>\n\n\n\n<li>Onay s\u00fcre\u00e7lerini h\u0131zland\u0131rmak<\/li>\n\n\n\n<li>Geri \u00f6deme sistemini yeniden d\u00fczenlemek<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"accountability-gap\">Hesap Verebilirlik A\u00e7\u0131\u011f\u0131<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Dernekler nadiren:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Siyasi taahh\u00fctleri kamuoyu \u00f6n\u00fcnde yay\u0131nlar<\/li>\n\n\n\n<li>Vaatlerini sonu\u00e7larla kar\u015f\u0131la\u015ft\u0131r\u0131r<\/li>\n\n\n\n<li>S\u00fcrekli bask\u0131 uygular<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bu durum, siyasi eylemsizli\u011fin denetimsiz bir \u015fekilde devam etmesine olanak tan\u0131r.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-2-the-myth-of-nothing-can-be-done\"><strong>\u201cHi\u00e7bir \u015fey yap\u0131lamaz\u201d efsanesi<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-3-global-models-that-contradict-this-narrative\">Bu Anlat\u0131y\u0131 \u00c7\u00fcr\u00fcten K\u00fcresel Modeller<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc ve S\u0131n\u0131r Tan\u0131mayan Doktorlar gibi kurulu\u015flar \u015funu g\u00f6stermi\u015ftir:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\u0130la\u00e7lara eri\u015fimdeki engeller a\u015f\u0131labilir.<\/li>\n\n\n\n<li>Fiyat konusunda pazarl\u0131k yap\u0131labilir.<\/li>\n\n\n\n<li>Da\u011f\u0131t\u0131m sistemleri kurulabilir.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Fark \u015furada yat\u0131yor:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Strateji<\/li>\n\n\n\n<li>Azim<\/li>\n\n\n\n<li>Sistemlere meydan okuma iste\u011fi<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"what-effective-advocacy-looks-like\">Etkili Savunuculuk Nas\u0131l G\u00f6r\u00fcn\u00fcr?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Ba\u015far\u0131l\u0131 modeller \u015funlard\u0131r:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Koordineli uluslararas\u0131 bask\u0131<\/li>\n\n\n\n<li>Eri\u015fime ili\u015fkin yasal \u00e7er\u00e7eveler<\/li>\n\n\n\n<li>Stratejik ortakl\u0131klar<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>DMD derneklerinin \u00e7o\u011fu bu standartlar\u0131n gerisinde kalmaktad\u0131r.<\/strong><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"the-structural-weakness-of-dmd-associations\"><strong>DMD Derneklerinin Yap\u0131sal Zay\u0131fl\u0131\u011f\u0131<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-3-lack-of-strategic-roadmaps\">Stratejik Yol Haritalar\u0131n\u0131n Eksikli\u011fi<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Az say\u0131da dernek \u015fu yay\u0131nlar\u0131 yap\u0131yor:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Net hedefler<\/li>\n\n\n\n<li>\u00d6l\u00e7\u00fclebilir hedefler<\/li>\n\n\n\n<li>\u015eeffaf ilerleme raporlar\u0131<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bunlar olmadan hesap verebilirlik imkans\u0131zd\u0131r.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"fragmentation-instead-of-collaboration\">\u0130\u015fbirli\u011fi Yerine Par\u00e7alanma<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Birle\u015fik k\u00fcresel \u00e7abalar yerine:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Dernekler birbirinden ba\u011f\u0131ms\u0131z olarak faaliyet g\u00f6sterir<\/li>\n\n\n\n<li>M\u00fckerrer \u00e7abalar harcarlar<\/li>\n\n\n\n<li>Veri payla\u015f\u0131m\u0131 kesinlikle ba\u015far\u0131s\u0131zd\u0131r<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Bu par\u00e7alanma ilerlemeyi \u00f6nemli \u00f6l\u00e7\u00fcde yava\u015flat\u0131yor.<\/strong><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"the-responsibility-to-deliver-not-just-represent\"><strong>Sadece temsil etmek de\u011fil, sonu\u00e7 elde etmek sorumlulu\u011fu<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-3-representation-is-not-enough\">Temsil Yeterli De\u011fil<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Dernekler s\u0131kl\u0131kla \"hastalar\u0131 temsil ettiklerini\" iddia ederler.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ancak sonu\u00e7suz temsil yetersizdir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Hastalar\u0131n ihtiyac\u0131 olanlar:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Eri\u015fim<\/li>\n\n\n\n<li>Tedavi<\/li>\n\n\n\n<li>Hayatta Kalma<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"the-urgency-of-dmd\">DMD&#039;nin Aciliyeti<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">DMD&#039;nin ilerleyi\u015fi amans\u0131zd\u0131r:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Kas dejenerasyonu<\/li>\n\n\n\n<li>Y\u00fcr\u00fcme yetene\u011finin kayb\u0131<\/li>\n\n\n\n<li>Kalp ve solunum yetmezli\u011fi<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Kaybedilen zaman geri kazan\u0131lamaz.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-2-what-needs-to-change-immediately\"><strong>Hemen De\u011fi\u015ftirilmesi Gerekenler<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-3-radical-transparency\">Radikal \u015eeffafl\u0131k<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Derneklerin yapmas\u0131 gerekenler:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>T\u00fcm g\u00f6r\u00fc\u015fmeleri yay\u0131nlamak<\/li>\n\n\n\n<li>Zaman \u00e7izelgelerini payla\u015fmak<\/li>\n\n\n\n<li>Ba\u015far\u0131s\u0131zl\u0131klar\u0131 a\u00e7\u0131k\u00e7a bildirmek<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-3-aggressive-advocacy\">Agresif Savunuculuk<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Bunlara \u015funlar dahildir:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Gerekli durumlarda yasal i\u015flem ba\u015flatmak<\/li>\n\n\n\n<li>Kamu kampanyalar\u0131<\/li>\n\n\n\n<li>Uluslararas\u0131 ittifaklar<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-3-data-driven-decision-making\">Veriye Dayal\u0131 Karar Verme<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Derneklerin yapmas\u0131 gerekenler:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Tedavi sonu\u00e7lar\u0131n\u0131 k\u00fcresel olarak takip etmek<\/li>\n\n\n\n<li>Ger\u00e7ek d\u00fcnya verilerini kullanmak<\/li>\n\n\n\n<li>Tedavi g\u00f6ren hastalarla do\u011frudan etkile\u015fim kurmak<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-3-holding-all-stakeholders-accountable\">T\u00fcm Payda\u015flar\u0131n Sorumlulu\u011funu \u00dcstlenmek<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Direkt ileti\u015fim kurulacak ki\u015fi ve kurumlar:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>H\u00fck\u00fcmet<\/li>\n\n\n\n<li>\u0130la\u00e7 \u015firketleri<\/li>\n\n\n\n<li>T\u0131p uzmanlar\u0131<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"dmd-associations-financial-transparency-and-accountability-issues\">DMD Derneklerinin Mali \u015eeffafl\u0131k ve Hesap Verebilirlik Sorunlar\u0131<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Bir\u00e7ok DMD derne\u011fiyle ilgili en b\u00fcy\u00fck endi\u015felerden biri, mali faaliyetlerine ili\u015fkin \u015feffafl\u0131k eksikli\u011fidir. Bir\u00e7ok durumda, y\u0131ll\u0131k gelir ve gider raporlar\u0131 ya hi\u00e7 yay\u0131nlanmamakta ya da belirsiz ve eksik bir \u015fekilde sunulmaktad\u0131r. <strong>Finansal bilgilerin \u015feffaf bir \u015fekilde a\u00e7\u0131klanmamas\u0131, ba\u011f\u0131\u015flar\u0131n nas\u0131l harcand\u0131\u011f\u0131 ve hastalar\u0131n tedaviye eri\u015fimini art\u0131rmak i\u00e7in etkili bir \u015fekilde kullan\u0131l\u0131p kullan\u0131lmad\u0131\u011f\u0131 konusunda ciddi sorular\u0131 g\u00fcndeme getiriyor.<\/strong> \u015eeffaf raporlama olmadan, hastalar\u0131n, ailelerin ve ba\u011f\u0131\u015f\u00e7\u0131lar\u0131n bu kurulu\u015flar\u0131n ger\u00e7ek etkisini de\u011ferlendirmesi imkans\u0131z hale gelir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ayr\u0131nt\u0131l\u0131 mali tablolar\u0131n yay\u0131nlanmamas\u0131, rakamlar\u0131 belirsizle\u015ftirmekten daha fazlas\u0131n\u0131 yapar; hesap verebilirli\u011fi zay\u0131flat\u0131r. <strong>Mali \u015feffafl\u0131ktan yoksun faaliyet g\u00f6steren dernekler, kendilerini denetimden muaf tutarak, temsil ettiklerini iddia ettikleri topluluklar i\u00e7indeki g\u00fcveni zay\u0131flat\u0131rlar.<\/strong> Duchenne kas distrofisi gibi ya\u015fam\u0131 s\u0131n\u0131rlayan bir hastal\u0131k ba\u011flam\u0131nda, her kayna\u011f\u0131n stratejik olarak eri\u015fime ve sonu\u00e7lara y\u00f6nlendirilmesi gerekirken, bu hesap verebilirlik eksikli\u011fi k\u00fc\u00e7\u00fck bir ihmal de\u011fil, sistemik bir ba\u015far\u0131s\u0131zl\u0131kt\u0131r.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"misuse-of-funds-when-travel-takes-priority-over-patients\">Ba\u011f\u0131\u015flar\u0131n K\u00f6t\u00fcye Kullan\u0131m\u0131: Seyahat, Hastalar\u0131n \u00d6n\u00fcne Ge\u00e7ti\u011finde<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Ailelerin bildirdi\u011fi en endi\u015fe verici uygulamalardan biri, dernek fonlar\u0131n\u0131n hastalara \u00f6l\u00e7\u00fclebilir bir fayda sa\u011flamayan &quot;seyahatler&quot; i\u00e7in kullan\u0131lmas\u0131d\u0131r. Bu harcamalar genellikle a\u011f kurma f\u0131rsatlar\u0131, konferanslar veya uluslararas\u0131 ziyaretler olarak sunulsa da, sonu\u00e7lar, sa\u011flanan anla\u015fmalar veya elde edilen somut ilerleme hakk\u0131nda \u015feffaf bir raporlama nadiren yap\u0131lmaktad\u0131r. <strong>Hastalar ve ba\u011f\u0131\u015f\u00e7\u0131lar taraf\u0131ndan finanse edilen kurulu\u015flar, sonu\u00e7lardan ziyade seyahat masraflar\u0131n\u0131 \u00f6nceliklendirdi\u011finde, temel bir soru ortaya \u00e7\u0131k\u0131yor: Bu faaliyetler ger\u00e7ekten tedaviye eri\u015fimi mi art\u0131r\u0131yor, yoksa sadece i\u015f yapm\u0131\u015f gibi g\u00f6r\u00fcn\u00fclmesini mi sa\u011fl\u0131yor?<\/strong> Zaman\u0131n \u00e7ok \u00f6nemli oldu\u011fu bir hastal\u0131kta, gereksiz harcamalara ayr\u0131lan her kaynak, ger\u00e7ek \u00e7\u00f6z\u00fcmler i\u00e7in \u00e7aba g\u00f6sterme f\u0131rsat\u0131n\u0131n ka\u00e7\u0131r\u0131lmas\u0131 anlam\u0131na gelir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Daha da endi\u015fe verici olan, bu harcamalarla ilgili hesap verebilirli\u011fin olmamas\u0131d\u0131r. <strong>Ailelerden ba\u011f\u0131\u015f yapmalar\u0131, kampanyalar\u0131 desteklemeleri ve fonlar\u0131n tedaviye eri\u015fim i\u00e7in m\u00fccadelede kullan\u0131laca\u011f\u0131na g\u00fcvenmeleri isteniyor; ancak seyahat i\u00e7in ne kadar harcand\u0131\u011f\u0131, bundan kimin faydaland\u0131\u011f\u0131 ve kar\u015f\u0131l\u0131\u011f\u0131nda hangi somut sonu\u00e7lar\u0131n elde edildi\u011fi konusunda \u00e7ok az bilgi veriliyor.<\/strong> Bu durum, baz\u0131 kurumlarda &quot;seyahatlerin&quot; stratejik ara\u00e7lar olarak de\u011fil, rutin ayr\u0131cal\u0131klar olarak normalle\u015fti\u011fi alg\u0131s\u0131n\u0131 yaratmaktad\u0131r. Aciliyetin her karar\u0131 belirlemesi gereken Duchenne kas distrofisi ba\u011flam\u0131nda, yetersiz gerek\u00e7elendirilmi\u015f seyahatlere yap\u0131lan harcamalar sadece sorgulanabilir de\u011fil, etik a\u00e7\u0131dan da savunulamazd\u0131r.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"faq\">S\u0131k\u00e7a Sorulan Sorular: \u00dclkenizdeki DMD Derneklerine Sorabilece\u011finiz Sorular!<\/h2>\n\n\n<div id=\"rank-math-faq\" class=\"rank-math-block\">\n<div class=\"rank-math-list\">\n<div id=\"faq-question-1774368888248\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">\u00dclkemde DMD tedavileri neden mevcut de\u011fil?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>Duchenne kas distrofisi tedavilerine eri\u015fim, d\u00fczenleyici onay, fiyat g\u00f6r\u00fc\u015fmeleri ve ulusal geri \u00f6deme politikalar\u0131 da dahil olmak \u00fczere bir\u00e7ok fakt\u00f6re ba\u011fl\u0131d\u0131r. Bir\u00e7ok \u00fclkede, h\u00fck\u00fcmetlerin nadir hastal\u0131klara \u00f6ncelik vermemesi, ila\u00e7 \u015firketlerinin lisans ba\u015fvurusunda bulunmamas\u0131 veya savunuculuk \u00e7abalar\u0131n\u0131n s\u00fcreci ilerletmek i\u00e7in yeterince g\u00fc\u00e7l\u00fc olmamas\u0131 nedeniyle gecikmeler ya\u015fanmaktad\u0131r. Derneklerden, politika yap\u0131c\u0131lardan ve hasta gruplar\u0131ndan gelen koordineli bir bask\u0131 olmadan, tedaviler y\u0131llarca eri\u015filemez durumda kalabilir.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1774368925369\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">DMD dernekleri tedaviye eri\u015fimden sorumlu mu?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>DMD dernekleri, tedaviye eri\u015fim konusunda savunuculuk yapmada kritik bir rol oynar, ancak tek karar verici de\u011fillerdir. Sorumluluklar\u0131, h\u00fck\u00fcmetlere bask\u0131 uygulamak, ila\u00e7 \u015firketleriyle ileti\u015fim kurmak ve hasta ihtiya\u00e7lar\u0131n\u0131 etkili bir \u015fekilde temsil etmektir. Dernekler sonu\u00e7 \u00fcretemedi\u011finde, bu genellikle zay\u0131f savunuculuk stratejilerini, \u015feffafl\u0131k eksikli\u011fini veya kilit payda\u015flarla yetersiz ileti\u015fimi yans\u0131t\u0131r.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1774368973354\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">Baz\u0131 DMD dernekleri neden sonu\u00e7 elde edemiyor?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>Ba\u015far\u0131s\u0131zl\u0131klar genellikle b\u00fcrokratik verimsizlik, stratejik planlama eksikli\u011fi, politika ve m\u00fczakere konusunda s\u0131n\u0131rl\u0131 uzmanl\u0131k ve yetkililere veya ila\u00e7 \u015firketlerine meydan okuma isteksizli\u011finin bir kombinasyonundan kaynaklan\u0131r. Baz\u0131 dernekler, onay ve geri \u00f6deme kararlar\u0131 gibi \u00f6l\u00e7\u00fclebilir sonu\u00e7lardan ziyade fark\u0131ndal\u0131k yaratma faaliyetlerine daha fazla odaklan\u0131r; bu da ger\u00e7ek d\u00fcnyadaki etkilerini s\u0131n\u0131rlar.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1774369002649\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">Tedavilere eri\u015fim m\u00fcmk\u00fcn de\u011filse aileler ne yapabilir?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>Aileler topluca \u00f6rg\u00fctlenebilir, derneklerden \u015feffafl\u0131k talep edebilir ve politika yap\u0131c\u0131lar ve medya ile do\u011frudan ileti\u015fim kurabilirler. Hasta koalisyonlar\u0131 kurmak, kamuoyunu bilin\u00e7lendirmek ve uluslararas\u0131 savunuculuk gruplar\u0131yla i\u015fbirli\u011fi yapmak, karar vericiler \u00fczerindeki bask\u0131y\u0131 art\u0131rabilir. Baz\u0131 durumlarda, yasal i\u015flem ba\u015flatmak veya klinik ara\u015ft\u0131rmalara kat\u0131lmak da uygulanabilir se\u00e7enekler olabilir.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1774369040191\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">DMD ila\u00e7lar\u0131 neden bu kadar pahal\u0131?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>DMD tedavileri, \u00f6zellikle gen terapileri, karma\u015f\u0131k ara\u015ft\u0131rma, geli\u015ftirme ve \u00fcretim s\u00fcre\u00e7leri nedeniyle maliyetlidir. \u0130la\u00e7 \u015firketleri ayr\u0131ca ila\u00e7 fiyatlar\u0131n\u0131 piyasa dinamiklerine ve beklenen getirilere g\u00f6re belirler. Ancak y\u00fcksek fiyatlar tek engel de\u011fildir; pazarl\u0131k eksikli\u011fi, kademeli fiyatland\u0131rma gibi fiyatland\u0131rma stratejilerinin olmamas\u0131 ve zay\u0131f savunuculuk eri\u015fimi daha da s\u0131n\u0131rlayabilir. Daha fazla bilgi i\u00e7in: <a href=\"https:\/\/dmdwarrior.com\/tr\/the-challenge-of-getting-dmd-gene-therapy-is-geography-destiny\/\" target=\"_blank\" rel=\"noreferrer noopener\">Co\u011frafya Kader midir?<\/a><\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1774369135348\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">Doktorlar\u0131n DMD tedavilerine eri\u015fimi iyile\u015ftirmede bir rol\u00fc var m\u0131?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>Evet, doktorlar k\u00fcresel tedavi geli\u015fmelerinden haberdar olarak, ara\u015ft\u0131rmalara katk\u0131da bulunarak ve hastalar\u0131n tedaviye eri\u015fimini savunarak \u00f6nemli bir rol oynarlar. Klinik denemeleri destekleyebilir, ger\u00e7ek d\u00fcnya verileri toplayabilir ve politika tart\u0131\u015fmalar\u0131n\u0131 etkileyebilirler. <strong>Doktorlar pasif kald\u0131klar\u0131nda veya \u00e7\u00f6z\u00fcm \u00f6nerileri sunmadan a\u015f\u0131r\u0131 ele\u015ftirel davrand\u0131klar\u0131nda, ilerleme yava\u015flayabilir.<\/strong><\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1774369172170\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">DMD dernekleri i\u00e7in finansal \u015feffafl\u0131k neden \u00f6nemlidir?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>Finansal \u015feffafl\u0131k, hastalar\u0131n, ailelerin ve ba\u011f\u0131\u015f\u00e7\u0131lar\u0131n fonlar\u0131n nas\u0131l kullan\u0131ld\u0131\u011f\u0131n\u0131 ve kurulu\u015fun misyonuyla uyumlu olup olmad\u0131\u011f\u0131n\u0131 anlamalar\u0131n\u0131 sa\u011flar. Gelir ve giderlerin a\u00e7\u0131k bir \u015fekilde raporlanmamas\u0131 durumunda, etkinli\u011fi de\u011ferlendirmek veya y\u00f6netimi sorumlu tutmak imkans\u0131zd\u0131r. \u015eeffafl\u0131k g\u00fcven olu\u015fturur ve kaynaklar\u0131n anlaml\u0131 sonu\u00e7lara y\u00f6nlendirilmesini sa\u011flar.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1774369249342\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">Geri \u00f6deme nedir ve neden \u00f6nemlidir?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>Geri \u00f6deme, bir sa\u011fl\u0131k sistemi veya sigorta sa\u011flay\u0131c\u0131s\u0131n\u0131n bir tedavinin maliyetini kar\u015f\u0131lay\u0131p kar\u015f\u0131lamad\u0131\u011f\u0131n\u0131 ifade eder. Bir ila\u00e7 onaylanm\u0131\u015f olsa bile, y\u00fcksek maliyetler nedeniyle \u00e7o\u011fu durumda hastalar geri \u00f6deme olmadan ilaca eri\u015femezler. Bu nedenle, geri \u00f6demenin sa\u011flanmas\u0131, DMD tedavilerine ger\u00e7ek eri\u015fimi sa\u011flaman\u0131n en kritik ad\u0131mlar\u0131ndan biridir.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1774369291323\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">Uluslararas\u0131 kurulu\u015flar eri\u015fimi iyile\u015ftirmeye yard\u0131mc\u0131 olabilir mi?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>Evet, uluslararas\u0131 i\u015f birli\u011fi eri\u015fimi \u00f6nemli \u00f6l\u00e7\u00fcde iyile\u015ftirebilir. K\u00fcresel sa\u011fl\u0131k \u00f6rg\u00fctleri, hasta a\u011flar\u0131 ve STK&#039;lar, \u00e7abalar\u0131 koordine etmeye, veri payla\u015fmaya ve s\u0131n\u0131rlar \u00f6tesinde bask\u0131 uygulamaya yard\u0131mc\u0131 olabilir. Di\u011fer hastal\u0131klarda ba\u015far\u0131l\u0131 modeller, birle\u015fik k\u00fcresel stratejilerin d\u00fczenleyici ve fiyatland\u0131rma engellerini a\u015fabilece\u011fini g\u00f6stermektedir.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1774369328446\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">Aileler bir DMD derne\u011finden ne beklemelidir?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>Aileler, net ileti\u015fim, \u00f6l\u00e7\u00fclebilir hedefler, \u015feffaf mali raporlama ve tedaviye eri\u015fim konusunda somut ilerleme beklemelidir. Dernekler sadece fark\u0131ndal\u0131k yaratmakla kalmamal\u0131, ayn\u0131 zamanda onaylar\u0131n al\u0131nmas\u0131, geri \u00f6demelerin sa\u011flanmas\u0131 ve terapilere e\u015fit eri\u015fimin g\u00fcvence alt\u0131na al\u0131nmas\u0131 i\u00e7in aktif olarak \u00e7al\u0131\u015fmal\u0131d\u0131r. En \u00f6nemlisi, temsil ettikleri hastalara kar\u015f\u0131 hesap verebilir olmal\u0131d\u0131rlar.<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-2-conclusion\"><strong>Sonu\u00e7<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Duchenne Musk\u00fcler Distrofisi (DMD) tedavisine eri\u015fimin mevcut durumu, karma\u015f\u0131kl\u0131\u011f\u0131n ka\u00e7\u0131n\u0131lmaz bir sonucu de\u011fil; sistemin yetersiz performans\u0131n\u0131n bir sonucudur.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A\u015fa\u011f\u0131daki \u00f6zelliklere sahip dernekler:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Tedavi ve ila\u00e7lara eri\u015fimi sa\u011flayam\u0131yorsa<\/li>\n\n\n\n<li>Sorumluluktan ka\u00e7\u0131n\u0131yorsa<\/li>\n\n\n\n<li>Sembolik eylemlere g\u00fcveniyorsa<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bunlar sadece etkisiz olmakla kalm\u0131yor, sorunun da bir par\u00e7as\u0131 oluyorlar.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Beklenti m\u00fckemmellik de\u011fil. <strong>Bu bir ilerleme.<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u0130lerlemenin olmad\u0131\u011f\u0131 yerde mutlaka inceleme yap\u0131lmal\u0131d\u0131r. <strong>Y\u00f6netim ekibi yenilenmelidir.<\/strong><\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\">\u00dclkenizdeki bir DMD derne\u011fi y\u0131ll\u0131k gelir ve gider tablolar\u0131n\u0131 yay\u0131nlam\u0131yorsa, ona ba\u011f\u0131\u015f yapmay\u0131n.<\/p>\n<\/blockquote>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Bu Sayfay\u0131 Takip Edin<\/strong>&nbsp;&gt;&gt;&gt;&nbsp;<a href=\"https:\/\/dmdwarrior.com\/tr\/dmd-therapies\/\" target=\"_blank\" rel=\"noreferrer noopener\">Duchenne i\u00e7in T\u00fcm Klinik Ara\u015ft\u0131rmalar<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Duchenne muscular dystrophy (DMD) is not a newly discovered condition, nor is it an unsolvable one. Scientific progress over the past two decades has produced exon-skipping therapies, corticosteroid optimization protocols, and most notably, gene therapies that are already approved in major regulatory jurisdictions. Yet, across large parts of the world, children with DMD remain untreated\u2014not [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":7077,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[282],"tags":[229,232,230,231,77,61],"class_list":["post-2739","post","type-post","status-publish","format-standard","has-post-thumbnail","category-editorials","tag-dmd-associations","tag-dmd-treatments","tag-duchenne-associations","tag-duchenne-treatments","tag-exon-skipping","tag-gene-therapy"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/2739","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/comments?post=2739"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/2739\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media\/7077"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media?parent=2739"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/categories?post=2739"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/tags?post=2739"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}